Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
|---|---|---|---|---|---|
| C0007137 | Squamous cell carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0001418 | Adenocarcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C1458155 | Mammary Neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0006142 | Malignant neoplasm of breast | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0002395 | Alzheimer's Disease | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0007107 | Malignant neoplasm of larynx | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0684249 | Carcinoma of lung | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0027651 | Neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C1306459 | Primary malignant neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0497327 | Dementia | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0152013 | Adenocarcinoma of lung (disorder) | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C4721555 | Autoimmune hepatitis | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0678222 | Breast Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0040136 | Thyroid Neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0006826 | Malignant Neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0006111 | Brain Diseases | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0242363 | Islet Cell Tumor | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0023467 | Leukemia, Myelocytic, Acute | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0023794 | Lipoidosis | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0004238 | Atrial Fibrillation | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0005695 | Bladder Neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0007131 | Non-Small Cell Lung Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0026650 | Movement Disorders | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0020459 | Hyperinsulinism | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
| C0021390 | Inflammatory Bowel Diseases | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
